Iwata T, Mori T , Tajiri H, Uesugi T, Nakazaki M Department of Stroke Treatment
description
Transcript of Iwata T, Mori T , Tajiri H, Uesugi T, Nakazaki M Department of Stroke Treatment
![Page 1: Iwata T, Mori T , Tajiri H, Uesugi T, Nakazaki M Department of Stroke Treatment](https://reader035.fdocuments.us/reader035/viewer/2022062501/568166b3550346895ddab4f1/html5/thumbnails/1.jpg)
Angioplasty and Stenting for the Internal Carotid or Middle Cerebral Artery Occlusion in
a Subacute Stroke Stage in Deteriorating Patients with
the Internal Border Zone Infarcts
Iwata T, Mori T, Tajiri H, Uesugi T, Nakazaki MDepartment of Stroke Treatment
Shonan Kamakura General Hospital Stroke Center, Kamakura City, Japan
![Page 2: Iwata T, Mori T , Tajiri H, Uesugi T, Nakazaki M Department of Stroke Treatment](https://reader035.fdocuments.us/reader035/viewer/2022062501/568166b3550346895ddab4f1/html5/thumbnails/2.jpg)
Background• Neurological symptoms of some patients with the
internal carotid artery (ICA) or the middle cerebral artery (MCA) occlusion are mild at onset but deteriorate day by day.
• Several days after the onset, the internal border zone (IBZ) infarcts occurs.
• However, it is not established how to treat them in a subacute stroke stage and how to improve their clinical outcome.
![Page 3: Iwata T, Mori T , Tajiri H, Uesugi T, Nakazaki M Department of Stroke Treatment](https://reader035.fdocuments.us/reader035/viewer/2022062501/568166b3550346895ddab4f1/html5/thumbnails/3.jpg)
Purpose
The internal border zone (IBZ) means an arterial border zone differentiated from the cortical border zone(CBZ). The purpose of our retrospective study is to investigate whether or not angioplasty and/or stenting for the ICA or MCA occlusion in a subacute stroke stage can improve clinical outcome in severely disabled patients due to the internal border zone (IBZ) infarcts.
![Page 4: Iwata T, Mori T , Tajiri H, Uesugi T, Nakazaki M Department of Stroke Treatment](https://reader035.fdocuments.us/reader035/viewer/2022062501/568166b3550346895ddab4f1/html5/thumbnails/4.jpg)
IBZ(A) and CBZ(B) infarcts
Contour map of frequency of affected sites in the IBZ (A) and CBZ (B) infarcts. The location of the IBZ can vary along the lateral ventricle, whereas the CBZ is distributed more heterogeneously as wedged areas that extend from the frontal and occipital horn of the lateral ventricle or within the paramedian white matter at the supraventricular level.
Seok Woo Yong, et.al. Stroke. 2006;37:841-846
![Page 5: Iwata T, Mori T , Tajiri H, Uesugi T, Nakazaki M Department of Stroke Treatment](https://reader035.fdocuments.us/reader035/viewer/2022062501/568166b3550346895ddab4f1/html5/thumbnails/5.jpg)
Patients (1)• Acute ischemic stroke patients• Period: Jan 2004 to Dec 2008• Onset-to arrival tine: within 72 hours• Emergency MRA showed the ICA or MCA occlusion • DWIs showed no extensive infarcts in the ICA or MCA
territory.• No cerebral hemorrhage on CT scans
![Page 6: Iwata T, Mori T , Tajiri H, Uesugi T, Nakazaki M Department of Stroke Treatment](https://reader035.fdocuments.us/reader035/viewer/2022062501/568166b3550346895ddab4f1/html5/thumbnails/6.jpg)
Patients (2)
• Their neurological symptoms were mild at onset and modified Rankin Scale (mRS) was 2 or less then.
• They deteriorated day by day despite dual antiplatelets.• Modified RS (mRS) was 4 or more on the 7th day. • CT scans or MR images on the 7th day demonstrated the
internal border zone (IBZ) infarcts.
![Page 7: Iwata T, Mori T , Tajiri H, Uesugi T, Nakazaki M Department of Stroke Treatment](https://reader035.fdocuments.us/reader035/viewer/2022062501/568166b3550346895ddab4f1/html5/thumbnails/7.jpg)
Groups of the patients
group E: patients who gave written informed consent and underwent
angioplasty and/or stenting for the ICA or MCA occlusion from 7 to 14 days after the stroke onset
group C: patients who did not.
![Page 8: Iwata T, Mori T , Tajiri H, Uesugi T, Nakazaki M Department of Stroke Treatment](https://reader035.fdocuments.us/reader035/viewer/2022062501/568166b3550346895ddab4f1/html5/thumbnails/8.jpg)
Evaluation• Patients’ baseline features• NIHSS on admission• NIHSS on the 7th day• NIHSS on discharge• Hospitalization periods• mRS on discharge • mRS at 3 months
Compared between two groups.
![Page 9: Iwata T, Mori T , Tajiri H, Uesugi T, Nakazaki M Department of Stroke Treatment](https://reader035.fdocuments.us/reader035/viewer/2022062501/568166b3550346895ddab4f1/html5/thumbnails/9.jpg)
Results (1) Group E Group C p Value
(n=6) (n=11) • Age, median,• (IR) [years] 71.5 (64-75) 82 (72-86) NS• Male sex , • no., (%) 4 (66.7%) 7 (63.6%) NS• Hypertension ,• no.(%) 6 (100.0%) 10 (90.9%) NS• Hyperlipidemia, • no.(%) 4 (66.7%) 6 (54.5%) NS • Diabetes mellitus,• no.(%) 4 (66.7%) 6 (54.5%) NS• MCA occlusion,• no., (%) 4 (66.7%) 8 (72.7%) NS
![Page 10: Iwata T, Mori T , Tajiri H, Uesugi T, Nakazaki M Department of Stroke Treatment](https://reader035.fdocuments.us/reader035/viewer/2022062501/568166b3550346895ddab4f1/html5/thumbnails/10.jpg)
Results (2)Group E Group C p Value
(n=6) (n=11)
NIHSS on admission,median, (IR) 6.5 (5.25-11.5) 6 (4-9.5) NSNIHSS on the 7th day, median, (IR) 13 (12-16.25) 12 (10-13.5) NSNIHSS on discharge,median, (IR) 7 (6.25-10.75) 13 (11-18.5) NSmRS on dischargemedian, (IR) 4.5 (4-5) 5 (4-5) NSHospitalizationperiod [days], (IR) 11 (11-11) 12 (9-13) NS
mRS at 3 month (m) 2.5 (2-3.75) 4(4-5.5) 0.0127**
![Page 11: Iwata T, Mori T , Tajiri H, Uesugi T, Nakazaki M Department of Stroke Treatment](https://reader035.fdocuments.us/reader035/viewer/2022062501/568166b3550346895ddab4f1/html5/thumbnails/11.jpg)
Case(the MCA Occlusion)
A 63-year-old woman was admitted to our institution, since her right-sided hemiparesis deteriorated over 60 hours.
![Page 12: Iwata T, Mori T , Tajiri H, Uesugi T, Nakazaki M Department of Stroke Treatment](https://reader035.fdocuments.us/reader035/viewer/2022062501/568166b3550346895ddab4f1/html5/thumbnails/12.jpg)
CT and MRI on admission (3rd day)
CT T2WI DWI
63-yo-female
![Page 13: Iwata T, Mori T , Tajiri H, Uesugi T, Nakazaki M Department of Stroke Treatment](https://reader035.fdocuments.us/reader035/viewer/2022062501/568166b3550346895ddab4f1/html5/thumbnails/13.jpg)
MRI and MRA on admissionMRA
PWI (time-intensity curve)
Left MCA territory
![Page 14: Iwata T, Mori T , Tajiri H, Uesugi T, Nakazaki M Department of Stroke Treatment](https://reader035.fdocuments.us/reader035/viewer/2022062501/568166b3550346895ddab4f1/html5/thumbnails/14.jpg)
Treatment and clinical course
She took dual antiplatelets agents. However, her neurological symptoms deteriorated day by day.
![Page 15: Iwata T, Mori T , Tajiri H, Uesugi T, Nakazaki M Department of Stroke Treatment](https://reader035.fdocuments.us/reader035/viewer/2022062501/568166b3550346895ddab4f1/html5/thumbnails/15.jpg)
Diagnostic left carotid angiography (6th day)
Total occlusionof the Left MCA
A-P view Lateral view
![Page 16: Iwata T, Mori T , Tajiri H, Uesugi T, Nakazaki M Department of Stroke Treatment](https://reader035.fdocuments.us/reader035/viewer/2022062501/568166b3550346895ddab4f1/html5/thumbnails/16.jpg)
Left MCA occlusion
Estimated length of the occlusion
Probable peripheral branch of the MCA opacified via collateral circulation
M1
![Page 17: Iwata T, Mori T , Tajiri H, Uesugi T, Nakazaki M Department of Stroke Treatment](https://reader035.fdocuments.us/reader035/viewer/2022062501/568166b3550346895ddab4f1/html5/thumbnails/17.jpg)
CT scans (8th day)The NIHSS score rose up to 30.
CT scans showed the IBZ infarcts.
![Page 18: Iwata T, Mori T , Tajiri H, Uesugi T, Nakazaki M Department of Stroke Treatment](https://reader035.fdocuments.us/reader035/viewer/2022062501/568166b3550346895ddab4f1/html5/thumbnails/18.jpg)
Balloon Angioplasty for the Left MCA Occlusion (9th day)
Gateway 2.0mm×12mm
Synchro-14S 300cm
Total occlusionof the Left MCA
AP view
![Page 19: Iwata T, Mori T , Tajiri H, Uesugi T, Nakazaki M Department of Stroke Treatment](https://reader035.fdocuments.us/reader035/viewer/2022062501/568166b3550346895ddab4f1/html5/thumbnails/19.jpg)
Successful balloon angioplasty (9th day)
Lateral viewAnteroposterior view
![Page 20: Iwata T, Mori T , Tajiri H, Uesugi T, Nakazaki M Department of Stroke Treatment](https://reader035.fdocuments.us/reader035/viewer/2022062501/568166b3550346895ddab4f1/html5/thumbnails/20.jpg)
Clinical outcome of the patient
• NIHSS on the 3rd day: 23• NIHSS on the 7th day: 30• NIHSS on the 11th day: 18• Hospitalization periods: 11 days• mRS on discharge: 5
• mRS at 3 months: 3
![Page 21: Iwata T, Mori T , Tajiri H, Uesugi T, Nakazaki M Department of Stroke Treatment](https://reader035.fdocuments.us/reader035/viewer/2022062501/568166b3550346895ddab4f1/html5/thumbnails/21.jpg)
ConclusionAngioplasty and stenting for the ICA or
MCA occlusion, even more than 7 days after the stroke onset, may be feasible and effective in improving their 3-month clinical outcome in severely disabled patients due to the internal border zone infarcts .
![Page 22: Iwata T, Mori T , Tajiri H, Uesugi T, Nakazaki M Department of Stroke Treatment](https://reader035.fdocuments.us/reader035/viewer/2022062501/568166b3550346895ddab4f1/html5/thumbnails/22.jpg)